December 14, 2021

Centene Corporation v. Gilead Sciences, Inc. et al

Track this case

Case Number:

3:21-cv-09634

See also:

Court:

California Northern

Nature of Suit:

Anti-Trust

Judge:

Edward M Chen

Firms

Companies

Sectors & Industries:

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. December 15, 2021

    Centene Hits Gilead With HIV Generic Antitrust Suit

    Managed care company Centene Corp. has hit Gilead Sciences Inc. with an antitrust suit in California federal court, accusing the pharmaceutical giant of conspiring with rivals to prevent generic versions of its blockbuster HIV treatment from entering the market even after patents had expired on the name-brand versions of those medications.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS